These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10758614)
1. Bone-scan-like pattern with 99Tcm(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism. Akbunar AT; Orhan B; Alper E Nucl Med Commun; 2000 Feb; 21(2):181-5. PubMed ID: 10758614 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions. Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327 [TBL] [Abstract][Full Text] [Related]
3. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia. Sahin M; Basoglu T; Albayrak S; Canbaz F; Yapici O Clin Nucl Med; 2001 Jan; 26(1):62-4. PubMed ID: 11139060 [TBL] [Abstract][Full Text] [Related]
4. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy. Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416 [TBL] [Abstract][Full Text] [Related]
5. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases. Lam AS; Kettle AG; O'Doherty MJ; Coakley AJ; Barrington SF; Blower PJ Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790 [TBL] [Abstract][Full Text] [Related]
6. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions. Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845 [TBL] [Abstract][Full Text] [Related]
8. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Wulfrank DA; Schelstraete KH; Small F; Fallais CJ Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315 [TBL] [Abstract][Full Text] [Related]
9. Quantitative radionuclide scanning in metabolic bone disease. Meindok H; Rapoport A; Oreopoulos DG; Rabinovich S; Meema HE; Meema S Nucl Med Commun; 1985 Mar; 6(3):141-8. PubMed ID: 3158846 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996 [TBL] [Abstract][Full Text] [Related]
11. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148 [TBL] [Abstract][Full Text] [Related]
12. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications. Basu S; Nair N; Awasare S; Tiwari BP; Asopa R; Nair C Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330 [TBL] [Abstract][Full Text] [Related]
13. 188Re(V)-DMSA revisited: preparation and biodistribution of a potential radiotherapeutic agent with low kidney uptake. Dadachova E; Chapman J Nucl Med Commun; 1998 Feb; 19(2):173-81. PubMed ID: 9548202 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections. Koukouraki S; Gaitanis I; Hatjipaulou A; Karkavitsas N Hell J Nucl Med; 2006; 9(2):99-102. PubMed ID: 16894413 [TBL] [Abstract][Full Text] [Related]
15. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma. Zissimopoulos A; Zanglis A; Andreopoulos D; Baziotis N Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022 [TBL] [Abstract][Full Text] [Related]
16. Technetium-99m(V)-dimercaptosuccinic acid osteotropism in Staphylococcus aureus-induced arthritis regulated by glucose-mediated acidification. Wu Z; Liu M; Feng J; Weilin ; Wu H; Wang J; Li Y Nucl Med Commun; 2009 May; 30(5):356-61. PubMed ID: 19431226 [TBL] [Abstract][Full Text] [Related]
17. Three phase 99Tcm (V)DMSA scintigraphy in Paget's disease: an indicator of pamidronate effect. Kobayashi H; Shigeno C; Sakahara H; Yamamoto T; Hosono M; Fujimoto R; Konishi J Br J Radiol; 1997 Oct; 70(838):1056-9. PubMed ID: 9404211 [TBL] [Abstract][Full Text] [Related]
18. 99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma? Watkinson JC; Lazarus CR; Maisey MN; Clarke SE Nucl Med Commun; 1989 Dec; 10(12):859-70. PubMed ID: 2560154 [TBL] [Abstract][Full Text] [Related]
19. Differential renal function measured by 99Tcm-DTPA and 99Tcm-DMSA in a complete unilateral renal obstruction rat model. van de Wiele C; Everaert K; van der Eecken H; van Haelst JP; Simons M; Dierckx RA Nucl Med Commun; 1997 Nov; 18(11):1036-9. PubMed ID: 9423203 [TBL] [Abstract][Full Text] [Related]
20. 99Tcm-citrate: a new bone imaging radiopharmaceutical. Bhatnagar A; Mishra P; Sharma R; Chuttani K; Chakravarty K; Jain CM; Mondal A; Chopra MK; Gupta A Nucl Med Commun; 1999 Nov; 20(11):1067-76. PubMed ID: 10572918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]